Drug Type Monoclonal antibody |
Synonyms humanized anti-Siglec-15 antibody(Mabworks Biotech), siglec-15 checkpoint inhibitor(Mabworks Biotech), MIL-104 |
Target |
Action inhibitors |
Mechanism Siglec-15 inhibitors(Sialic acid-binding Ig-like lectin 15 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Head and Neck Neoplasms | Discovery | China | 23 Sep 2020 | |
| Lung Cancer | Discovery | China | 23 Sep 2020 | |
| Uterine Neoplasms | Discovery | China | 23 Sep 2020 |






